Nagase/Hayashibara will be attending the AAPS 2023 PharmSci 360 in Orlando
Press release
Nagase/Hayashibara will be attending the AAPS 2023 PharmSci 360 in Orlando, FL, USA.
AAPS 2023 PharmSci 360 in Orlando, FL, Orange County Convention Center
Nagase/Hayashibara Booth #3046
Poster Session M0930-04-23, Oct 23, 9:30-10:30
Title: Beneficial Effects of Trehalose on Mesenchymal Stem Cell-Derived Exosomes
Hayashibara is a carbohydrate manufacturing company of NAGASE Group which is the first company to successfully produce Trehalose on a commercial scale. Their pharma ingredients are:
- Trehalose
- Maltose
- Pullulan
- Sucrose (Reagent grade available now. Commercial grade will be available soon.)
Learn more here https://www.nagase.com/products/pharmaceutical-ingredients
Please visit booth #3046 to meet the Nagase/Hayashibara experts and learn more about their excipients and studies about Trehalose.
White paper of Trehalose injectable grade is now available for download: https://www.nagase.com/resources/a-smart-solution-for-biopharmaceutical-development